Unknown

Dataset Information

0

MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods.


ABSTRACT: In patients with multiple myeloma, obtaining posttreatment minimal residual disease (MRD) negativity is associated with longer progression-free survival and overall survival. Here, we compared the diagnostic performance of a single 10-color tube with that of a EuroFlow 8-color 2-tube panel for MRD testing. Bone marrow samples from 41 multiple myeloma patients were tested in parallel using the 2 approaches. Compared with the sum of the cells from the EuroFlow two 8-color tubes, the Memorial Sloan Kettering Cancer Center (MSKCC) single 10-color tube had a slight reduction in total cell number with a mean ratio of 0.85 (range, 0.57-1.46; P < .05), likely attributable to permeabilization of the cells. Percent of plasma cells showed a high degree of concordance (r2 = 0.97) as did normal plasma cells (r2 = 0.96), consistent with no selective plasma cell loss. Importantly, concordant measurement of residual disease burden was seen with abnormal plasma cells (r2 = 0.97). The overall concordance between the 2 tests was 98%. In 1 case, there was a discrepancy near the limit of detection of both tests in favor of the slightly greater theoretical sensitivity of the EuroFlow 8-color 2-tube panel (analytical sensitivity limit of MSKCC single 10-color tube: 6 cells in 1 million with at least 3 million cell acquisitions; EuroFlow 8-color 2-tube panel: 2 cells in 1 million with the recommended 10 million cell acquisitions).

SUBMITTER: Roshal M 

PROVIDER: S-EPMC5728052 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods.

Roshal Mikhail M   Flores-Montero Juan A JA   Gao Qi Q   Koeber Maesa M   Wardrope Jessica J   Durie Brian G M BGM   Dogan Ahmet A   Orfao Alberto A   Landgren Ola O  

Blood advances 20170503 12


In patients with multiple myeloma, obtaining posttreatment minimal residual disease (MRD) negativity is associated with longer progression-free survival and overall survival. Here, we compared the diagnostic performance of a single 10-color tube with that of a EuroFlow 8-color 2-tube panel for MRD testing. Bone marrow samples from 41 multiple myeloma patients were tested in parallel using the 2 approaches. Compared with the sum of the cells from the EuroFlow two 8-color tubes, the Memorial Sloan  ...[more]

Similar Datasets

| S-EPMC7464347 | biostudies-literature
| S-EPMC5802510 | biostudies-literature
| S-EPMC10632351 | biostudies-literature
| S-EPMC7056740 | biostudies-literature
| S-EPMC10475030 | biostudies-literature
| S-EPMC7603393 | biostudies-literature
| S-EPMC9928796 | biostudies-literature
| S-EPMC8508145 | biostudies-literature
| S-EPMC7449571 | biostudies-literature
| S-EPMC5571752 | biostudies-other